| 0 |
SPINAL CORD INFARCTION |
1 |
0.0023 |
| 1 |
MASTOCYTOSIS |
1 |
0.0021 |
| 2 |
TOXIC ANTERIOR SEGMENT SYNDROME |
2 |
0.0018 |
| 3 |
VASOSPASM |
1 |
0.0011 |
| 4 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 5 |
BRUGADA SYNDROME |
1 |
0.0010 |
| 6 |
MYELITIS |
1 |
0.0006 |
| 7 |
GENE MUTATION |
1 |
0.0005 |
| 8 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 9 |
URINARY HESITATION |
1 |
0.0004 |
| 10 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 11 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 12 |
HYPERVENTILATION |
2 |
0.0003 |
| 13 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 14 |
NEPHRITIS |
1 |
0.0003 |
| 15 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 16 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 17 |
TONGUE OEDEMA |
1 |
0.0003 |
| 18 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 19 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 20 |
SELF-MEDICATION |
1 |
0.0002 |
| 21 |
PULSE ABSENT |
1 |
0.0002 |
| 22 |
TRISMUS |
1 |
0.0002 |
| 23 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 24 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 25 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 26 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 27 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 28 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 29 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 30 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 31 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 32 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 33 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 34 |
NEUROTOXICITY |
1 |
0.0001 |
| 35 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 36 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 37 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 38 |
SHOCK |
1 |
0.0000 |
| 39 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 40 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 41 |
SKIN ULCER |
1 |
0.0000 |
| 42 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 43 |
PALLOR |
1 |
0.0000 |
| 44 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 45 |
MEDICATION ERROR |
2 |
0.0000 |
| 46 |
BLISTER |
2 |
0.0000 |
| 47 |
CONVULSION |
2 |
0.0000 |
| 48 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 49 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 50 |
OSTEONECROSIS |
1 |
0.0000 |
| 51 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 52 |
URINARY RETENTION |
1 |
0.0000 |
| 53 |
RASH MACULAR |
1 |
0.0000 |
| 54 |
HEART RATE DECREASED |
1 |
0.0000 |
| 55 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 56 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 57 |
RESTLESSNESS |
1 |
0.0000 |
| 58 |
AGITATION |
2 |
0.0000 |
| 59 |
EYE SWELLING |
1 |
0.0000 |
| 60 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 61 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 62 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 63 |
ARRHYTHMIA |
1 |
0.0000 |
| 64 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 65 |
SYNCOPE |
2 |
0.0000 |
| 66 |
EYE PAIN |
1 |
0.0000 |
| 67 |
DYSPHONIA |
1 |
0.0000 |
| 68 |
FEELING HOT |
1 |
0.0000 |
| 69 |
SWELLING FACE |
1 |
0.0000 |
| 70 |
ERYTHEMA |
3 |
0.0000 |
| 71 |
DRUG INTERACTION |
2 |
0.0000 |
| 72 |
DYSPHAGIA |
1 |
0.0000 |
| 73 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 74 |
PAIN |
6 |
0.0000 |
| 75 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 76 |
HYPERHIDROSIS |
1 |
0.0000 |
| 77 |
RENAL FAILURE |
1 |
0.0000 |
| 78 |
PARAESTHESIA |
1 |
0.0000 |
| 79 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 80 |
URTICARIA |
1 |
0.0000 |
| 81 |
MUSCLE SPASMS |
1 |
0.0000 |
| 82 |
PRURITUS |
2 |
0.0000 |
| 83 |
RASH |
2 |
0.0000 |
| 84 |
MALAISE |
2 |
0.0000 |
| 85 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 86 |
DIZZINESS |
2 |
0.0000 |
| 87 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 88 |
PYREXIA |
1 |
0.0000 |
| 89 |
NAUSEA |
2 |
0.0000 |
| 90 |
VOMITING |
1 |
0.0000 |